July 21, 2017
NantKwest CEO Patrick Soon-Shiong.
Stories this photo appears in:
El Segundo-based NantKwest Inc. and Sawtelle-based stem cell bank operator Generate Life Sciences Co. are collaborating on a stem cell-based treatment against Covid-19, the two companies announced Aug. 10.
NantKwest, ImmunityBio in the hunt for virus vaccine
Developments have been coming at a rapid clip since late May for the effort by two of Patrick Soon-Shiong’s companies — El Segundo-based NantKwest Inc. and ImmunityBio Inc. — to come up with a vaccine for Covid-19.
NantKwest Inc., a biotechnology company launched by Los Angeles businessman Patrick Soon-Shiong, raised $39 million in a private placement by its chairman and chief executive to advance a natural killer cell treatment for cancer.
NantCell Inc., a Culver City-based biotech firm founded by Los Angeles billionaire Patrick Soon-Shiong, has raised $30 million in investor funding, according to a Dec. 28 securities filing.
Nanthealth Inc. of Culver City, part of a health care conglomerate owned by Los Angeles billionaire Patrick Soon-Shiong, on March 14 reported a net loss last year of $175 million, while revenue grew by 8 percent.
Two leading L.A. biotech companies reported third-quarter losses Thursday, while announcing increased sales of cancer treatments.
HEALTH CARE: El Segundo base for anti-cancer components.
Billionaire Patrick Soon-Shiong has pledged to bring manufacturing jobs to El Segundo as part of his cancer treatment initiative.